Since its inception in 1983, DYPU has been a leader in higher education, emphasising research as a cornerstone of learning.

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) ...

Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...

High-impact workshop on ‘Biotechnology Applications for Crop Improvement’ highlights genetically modified and gene-edited ...

Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

Newsday Zimbabwe ZIMBABWE’S scientific and academic landscape is set for a major transformation as France will today hand ...

The lag in funding extends far beyond D.E.I. initiatives, affecting almost every area of science: chemistry, computing, ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

Syantra, Inc., has recently completed new patent filings that expand previous work in cancer molecular diagnostics to encompass new drug targets and therapeutics.

A webcast of the presentation can be found under the IR Events tab of the Tonix website at www.tonixpharma.com.

Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...